CAS 142001-63-6
:Saredutant
Description:
Saredutant, with the CAS number 142001-63-6, is a chemical compound that has been investigated primarily for its potential therapeutic applications, particularly in the treatment of psychiatric disorders such as depression and anxiety. It functions as a selective antagonist of the neurokinin-1 (NK1) receptor, which is involved in the modulation of mood and stress responses. By blocking this receptor, Saredutant may help alleviate symptoms associated with these conditions. The compound is characterized by its specific binding affinity to the NK1 receptor, which distinguishes it from other substances that may interact with different neurochemical pathways. Additionally, Saredutant has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, which are crucial for determining its efficacy and safety profile in clinical settings. Ongoing research continues to explore its full potential and mechanisms of action, contributing to the understanding of neurokinin signaling in mental health.
Formula:C31H35Cl2N3O2
InChI:InChI=1S/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37)/t26-/m1/s1
InChI key:InChIKey=PGKXDIMONUAMFR-AREMUKBSSA-N
SMILES:N(C(C)=O)C1(CCN(CC[C@H](CN(C(=O)C2=CC=CC=C2)C)C3=CC(Cl)=C(Cl)C=C3)CC1)C4=CC=CC=C4
Synonyms:- Benzamide, N-[(2S)-4-[4-(acetylamino)-4-phenyl-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methyl-
- Benzamide, N-[4-[4-(acetylamino)-4-phenyl-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methyl-, (S)-
- N-[(2S)-4-[4-(Acetylamino)-4-phenyl-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
- N-[(2S)-4-[4-(acetylamino)-4-phenylpiperidin-1-yl]-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
- Sr 48968
- Sr 48968C
- Saredutant
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Saredutant
CAS:<p>Saredutant is a potent, selective, and orally bioavailable antagonist of the glucocorticoid receptor. This drug has been approved for the treatment of IBD (inflammatory bowel disease) in Japan. Saredutant has also been shown to be effective for treating cancer and bowel disorders that are induced by inflammation. Saredutant is a potent anti-inflammatory agent that inhibits neutrophil infiltration into the inflamed bowel mucosa and reduces mucosal edema. It also inhibits CD4+ T cells from producing proinflammatory cytokines such as IL-2, IFN-γ, and TNF-α. Saredutant has been shown to reduce systolic blood pressure in animal studies, suggesting that it may have antihypertensive effects.</p>Formula:C31H35Cl2N3O2Purity:Min. 95%Molecular weight:552.5 g/molSaredutant
CAS:Saredutant (SR 48968) is a selective neurokinin-2 (NK2) receptor antagonist that inhibits neurokinin A by blocking NK2 receptor, antidepressant and anxiolytic.Formula:C31H35Cl2N3O2Purity:99.12%Color and Shape:SolidMolecular weight:552.54




